Midwest Financial Group LLC Sells 2,141 Shares of Lam Research Corporation $LRCX

Midwest Financial Group LLC reduced its stake in Lam Research Corporation (NASDAQ:LRCX) by 77.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 635 shares of the semiconductor company’s stock after selling 2,141 shares during the period. Midwest Financial Group LLC’s holdings in Lam Research were worth $275,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Bayban purchased a new position in Lam Research during the 4th quarter valued at about $26,000. Vermillion Wealth Management Inc. acquired a new position in shares of Lam Research during the first quarter worth $26,000. Cedar Mountain Advisors LLC increased its position in Lam Research by 242.9% during the 1st quarter. Cedar Mountain Advisors LLC now owns 120 shares of the semiconductor company’s stock valued at $26,000 after buying an additional 85 shares in the last quarter. Mcguire Capital Advisors Inc. acquired a new position in shares of Lam Research during the fourth quarter valued at about $27,000. Finally, Triumph Capital Management purchased a new position in shares of Lam Research in the third quarter worth $27,000. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Insider Activity

In other news, Director Abhijit Y. Talwalkar sold 18,282 shares of Lam Research stock in a transaction on Monday, July 13th. The shares were sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the completion of the sale, the director directly owned 87,142 shares of the company’s stock, valued at approximately $29,192,570. The trade was a 17.34% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eric Brandt sold 54,500 shares of the business’s stock in a transaction that occurred on Thursday, June 11th. The stock was sold at an average price of $350.80, for a total value of $19,118,600.00. Following the sale, the director owned 199,205 shares of the company’s stock, valued at approximately $69,881,114. The trade was a 21.48% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 80,441 shares of company stock worth $27,614,296. Corporate insiders own 0.31% of the company’s stock.

Lam Research Stock Down 6.3%

Shares of NASDAQ LRCX opened at $307.17 on Thursday. The company has a quick ratio of 1.91, a current ratio of 2.63 and a debt-to-equity ratio of 0.30. The firm has a market cap of $384.37 billion, a price-to-earnings ratio of 53.33, a PEG ratio of 1.30 and a beta of 1.84. Lam Research Corporation has a 52-week low of $94.11 and a 52-week high of $438.50. The business’s 50 day moving average is $339.57 and its two-hundred day moving average is $285.35.

Lam Research (NASDAQ:LRCX) last posted its earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.69 by $0.13. The firm had revenue of $6.72 billion for the quarter, compared to analyst estimates of $6.66 billion. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.Lam Research’s revenue was up 30.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.33 EPS. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. Research analysts predict that Lam Research Corporation will post 9.32 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the company. Raymond James Financial set a $425.00 price objective on Lam Research in a research note on Wednesday, June 10th. Wells Fargo & Company reissued an “overweight” rating and set a $350.00 target price (down from $450.00) on shares of Lam Research in a research note on Thursday, July 30th. B. Riley Financial decreased their target price on Lam Research from $385.00 to $350.00 and set a “buy” rating on the stock in a research report on Thursday, July 30th. HSBC reaffirmed a “hold” rating and issued a $333.00 price target on shares of Lam Research in a research note on Monday, July 27th. Finally, Bank of America lifted their target price on shares of Lam Research from $330.00 to $480.00 and gave the stock a “buy” rating in a research note on Tuesday, June 23rd. One research analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $358.47.

Lam Research Company Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.